These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 7649958

  • 1. Do high doses of stimulants impair flexible thinking in attention-deficit hyperactivity disorder?
    Douglas VI, Barr RG, Desilets J, Sherman E.
    J Am Acad Child Adolesc Psychiatry; 1995 Jul; 34(7):877-85. PubMed ID: 7649958
    [Abstract] [Full Text] [Related]

  • 2. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM, Coghill DR, Matthews K.
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [Abstract] [Full Text] [Related]

  • 3. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
    Coghill DR, Rhodes SM, Matthews K.
    Biol Psychiatry; 2007 Nov 01; 62(9):954-62. PubMed ID: 17543895
    [Abstract] [Full Text] [Related]

  • 4. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.
    Pearson DA, Santos CW, Casat CD, Lane DM, Jerger SW, Roache JD, Loveland KA, Lachar D, Faria LP, Payne CD, Cleveland LA.
    J Am Acad Child Adolesc Psychiatry; 2004 Jun 01; 43(6):677-85. PubMed ID: 15167084
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
    Sonuga-Barke EJ, Swanson JM, Coghill D, DeCory HH, Hatch SJ.
    BMC Psychiatry; 2004 Sep 30; 4():28. PubMed ID: 15458569
    [Abstract] [Full Text] [Related]

  • 6. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.
    Pearson DA, Lane DM, Santos CW, Casat CD, Jerger SW, Loveland KA, Faria LP, Mansour R, Henderson JA, Payne CD, Roache JD, Lachar D, Cleveland LA.
    J Am Acad Child Adolesc Psychiatry; 2004 Jun 30; 43(6):686-98. PubMed ID: 15167085
    [Abstract] [Full Text] [Related]

  • 7. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder.
    Kent JD, Blader JC, Koplewicz HS, Abikoff H, Foley CA.
    Pediatrics; 1995 Aug 30; 96(2 Pt 1):320-5. PubMed ID: 7630692
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.
    Tannock R, Ickowicz A, Schachar R.
    J Am Acad Child Adolesc Psychiatry; 1995 Jul 30; 34(7):886-96. PubMed ID: 7649959
    [Abstract] [Full Text] [Related]

  • 9. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS, Chao CC, Wu YY, Chen YY, Chen CK.
    Psychiatry Clin Neurosci; 2007 Jun 30; 61(3):219-25. PubMed ID: 17472588
    [Abstract] [Full Text] [Related]

  • 10. Effects of methylphenidate on attention and nonverbal learning in children with attention-deficit hyperactivity disorder.
    O'Toole K, Abramowitz A, Morris R, Dulcan M.
    J Am Acad Child Adolesc Psychiatry; 1997 Apr 30; 36(4):531-8. PubMed ID: 9100428
    [Abstract] [Full Text] [Related]

  • 11. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Arch Gen Psychiatry; 2005 Nov 30; 62(11):1266-74. PubMed ID: 16275814
    [Abstract] [Full Text] [Related]

  • 12. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr 30; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 13. Methylphenidate dosing: twice daily versus three times daily.
    Stein MA, Blondis TA, Schnitzler ER, O'Brien T, Fishkin J, Blackwell B, Szumowski E, Roizen NJ.
    Pediatrics; 1996 Oct 30; 98(4 Pt 1):748-56. PubMed ID: 8885956
    [Abstract] [Full Text] [Related]

  • 14. Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models.
    Denney CB, Rapport MD.
    J Am Acad Child Adolesc Psychiatry; 1999 Apr 30; 38(4):393-401. PubMed ID: 10199110
    [Abstract] [Full Text] [Related]

  • 15. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
    Bental B, Tirosh E.
    J Clin Psychopharmacol; 2008 Feb 30; 28(1):89-92. PubMed ID: 18204348
    [Abstract] [Full Text] [Related]

  • 16. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Law SF, Schachar RJ.
    J Am Acad Child Adolesc Psychiatry; 1999 Aug 30; 38(8):944-51. PubMed ID: 10434485
    [Abstract] [Full Text] [Related]

  • 17. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
    Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD.
    J Am Acad Child Adolesc Psychiatry; 1992 Mar 30; 31(2):226-34. PubMed ID: 1564023
    [Abstract] [Full Text] [Related]

  • 18. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder.
    Barkley RA, Murphy KR, O'Connell T, Connor DF.
    J Safety Res; 2005 Mar 30; 36(2):121-31. PubMed ID: 15896352
    [Abstract] [Full Text] [Related]

  • 19. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
    Pan XX, Ma HW, Wan B, Dai XM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug 30; 10(4):471-4. PubMed ID: 18706164
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I, Yoran-Hegesh R, Strous RD, Kotler M, Weizman A, Spivak B.
    Clin Neuropharmacol; 2009 Aug 30; 32(4):179-82. PubMed ID: 19644227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.